REMS (Risk Evaluation and Mitigation Strategy)
What is it?
A REMS is a risk management strategy the FDA can require for a medicine with serious safety concerns, to make sure its benefits still outweigh its risks once it's in routine use. It's the closest US equivalent to an EU RMP, built from a menu of tools that scales up with how much extra caution the drug actually needs.
Not every REMS looks the same. A lower-risk product might get away with a Medication Guide alone. A higher-risk one can require restricted dispensing through certified pharmacies, prescriber certification, and a patient registry, collectively known as Elements to Assure Safe Use, or ETASU.
The toolkit scales with the risk
Select a risk level to see which tools come with it.
Select a risk level to fill the toolboxCommon Misconceptions
"REMS and RMP: same idea, just different acronyms for the same paperwork?"
They share a purpose but not a system. REMS is an FDA requirement that can include enforceable restrictions like certified pharmacies or prescriber certification, while an RMP is the EU's framework, structured differently even where the underlying goal overlaps.
